Patton, E. Elizabeth http://orcid.org/0000-0002-2570-0834
Zon, Leonard I.
Langenau, David M. http://orcid.org/0000-0001-6664-8318
Article History
Accepted: 12 April 2021
First Online: 11 June 2021
Competing interests
: L.I.Z. is a founder and stockholder of Fate Therapeutics, CAMP4 Therapeutics, Amagma Therapeutics and Scholar Rock. He is a consultant for Celularity and Cellarity. D.M.L. has a sponsored research agreement with NextCure and patents issued/pending on immune-deficient zebrafish. E.E.P. declares no competing interests.